Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

mckesson corp. - MCK

MCK

Close Chg Chg %
719.32 -8.07 -1.12%

Closed Market

711.26

-8.07 (1.12%)

Volume: 522.43K

Last Updated:

Sep 12, 2025, 3:59 PM EDT

Trade Now

Company Overview: mckesson corp. - MCK

MCK Key Data

Open

$717.85

 Day Range

710.58 - 724.00

52 Week Range

464.42 - 737.89

 Market Cap

$89.53B

Shares Outstanding

124.38M

 Public Float

124.34M

Beta

0.51

 Rev. Per Employee

N/A

P/E Ratio

28.72

 EPS

$25.19

Yield

39.46%

 Dividend

$0.82

EX-DIVIDEND DATE

Sep 2, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

723.15K

  

MCK Performance

1 Week
 
 4.71%
 
1 Month
 
 6.95%
 
3 Months
 
 -1.15%
 
1 Year
 
 38.74%
 
5 Years
 
 378.69%
 

MCK Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 19
Full Ratings ➔

About mckesson corp. - MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

MCK At a Glance

McKesson Corp.
6555 State Highway 161
Irving, Texas 75039
Phone 1-972-446-4800 Revenue 359.05B
Industry Medical Distributors Net Income 3.30B
Sector Distribution Services 2025 Sales Growth 16.216%
Fiscal Year-end 03 / 2026 Employees 45,000
View SEC Filings

MCK Valuation

P/E Current 28.721
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 26.164
Price to Sales Ratio 0.24
Price to Book Ratio N/A
Price to Cash Flow Ratio 14.168
Enterprise Value to EBITDA 17.577
Enterprise Value to Sales 0.245
Total Debt to Enterprise Value 0.084

MCK Efficiency

Revenue/Employee 7,978,911.111
Income Per Employee 73,222.222
Receivables Turnover 14.002
Total Asset Turnover 5.036

MCK Liquidity

Current Ratio 0.899
Quick Ratio 0.526
Cash Ratio 0.097

MCK Profitability

Gross Margin 3.477
Operating Margin 1.218
Pretax Margin 1.214
Net Margin 0.918
Return on Assets 4.622
Return on Equity N/A
Return on Total Capital 61.983
Return on Invested Capital 73.705

MCK Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 139.014
Total Debt to Total Assets 9.835
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 111.757
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Mckesson Corp. - MCK

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
263.97B 276.71B 308.95B 359.05B
Sales Growth
+10.80% +4.83% +11.65% +16.22%
Cost of Goods Sold (COGS) incl D&A
251.32B 264.84B 296.75B 346.57B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.00B 857.00M 635.00M 636.00M
Depreciation
520.00M 497.00M 253.00M 242.00M
Amortization of Intangibles
481.00M 360.00M 382.00M 394.00M
COGS Growth
+10.89% +5.38% +12.05% +16.79%
Gross Income
12.65B 11.87B 12.20B 12.48B
Gross Income Growth
+9.21% -6.17% +2.81% +2.32%
Gross Profit Margin
+4.79% +4.29% +3.95% +3.48%
2022 2023 2024 2025 5-year trend
SG&A Expense
9.93B 7.42B 8.28B 8.11B
Research & Development
70.00M 89.00M 77.00M 91.00M
Other SG&A
9.86B 7.33B 8.20B 8.02B
SGA Growth
+22.97% -25.29% +11.58% -1.96%
Other Operating Expense
- - - -
-
Unusual Expense
876.00M (257.00M) 51.00M (99.00M)
EBIT after Unusual Expense
1.85B 4.71B 3.88B 4.47B
Non Operating Income/Expense
259.00M 168.00M 156.00M 144.00M
Non-Operating Interest Income
10.00M 107.00M 118.00M 173.00M
Equity in Earnings of Affiliates
43.00M 5.00M 4.00M 9.00M
Interest Expense
178.00M 248.00M 243.00M 256.00M
Interest Expense Growth
-17.97% +39.33% -2.02% +5.35%
Gross Interest Expense
178.00M 248.00M 243.00M 256.00M
Interest Capitalized
- - - -
-
Pretax Income
1.93B 4.63B 3.79B 4.36B
Pretax Income Growth
+138.30% +140.15% -18.16% +15.04%
Pretax Margin
+0.73% +1.67% +1.23% +1.21%
Income Tax
636.00M 905.00M 629.00M 878.00M
Income Tax - Current - Domestic
362.00M 745.00M 1.10B 734.00M
Income Tax - Current - Foreign
240.00M 180.00M 134.00M 254.00M
Income Tax - Deferred - Domestic
72.00M (10.00M) (493.00M) 107.00M
Income Tax - Deferred - Foreign
(38.00M) (10.00M) (110.00M) (217.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
43.00M 5.00M 4.00M 9.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.29B 3.73B 3.16B 3.48B
Minority Interest Expense
173.00M 162.00M 158.00M 186.00M
Net Income
1.12B 3.56B 3.00B 3.29B
Net Income Growth
+124.66% +218.41% -15.75% +9.76%
Net Margin Growth
+0.42% +1.29% +0.97% +0.92%
Extraordinaries & Discontinued Operations
- - (5.00M) (3.00M)
-
Discontinued Operations
- - (5.00M) (3.00M)
-
Net Income After Extraordinaries
1.11B 3.56B 3.00B 3.29B
Preferred Dividends
- - - -
-
Net Income Available to Common
1.11B 3.56B 3.00B 3.29B
EPS (Basic)
7.3145 25.2303 22.5375 25.8634
EPS (Basic) Growth
+125.88% +244.94% -10.67% +14.76%
Basic Shares Outstanding
152.30M 141.10M 133.20M 127.40M
EPS (Diluted)
7.2291 25.0352 22.3863 25.7221
EPS (Diluted) Growth
+125.58% +246.31% -10.58% +14.90%
Diluted Shares Outstanding
154.10M 142.20M 134.10M 128.10M
EBITDA
3.72B 5.31B 4.56B 5.01B
EBITDA Growth
-21.29% +42.59% -14.09% +9.78%
EBITDA Margin
+1.41% +1.92% +1.48% +1.39%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 798.571
Number of Ratings 19 Current Quarters Estimate 8.858
FY Report Date 09 / 2025 Current Year's Estimate 37.499
Last Quarter’s Earnings 8.26 Median PE on CY Estimate N/A
Year Ago Earnings 33.05 Next Fiscal Year Estimate 42.019
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 16 15
Mean Estimate 8.86 9.77 37.50 42.02
High Estimates 9.45 9.95 37.81 42.95
Low Estimate 8.17 9.19 35.76 39.38
Coefficient of Variance 3.47 2.11 1.27 1.91

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 12
OVERWEIGHT 3 3 3
HOLD 4 4 3
UNDERWEIGHT 0 0 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Mckesson Corp. - MCK

Date Name Shares Transaction Value
Jun 12, 2025 Brian Scott Tyler Chief Executive Officer; Director 47,243 Bona fide gift 0.00
May 22, 2025 Napoleon B. Rutledge SVP, Controller & CAO 1,972 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $726.51 per share 1,432,677.72
May 22, 2025 Napoleon B. Rutledge SVP, Controller & CAO 223 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Michele M. Lau EVP and Chief Legal Officer 2,808 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $605 per share 1,698,840.00
Feb 13, 2025 Michele M. Lau EVP and Chief Legal Officer 459 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $595.69 per share 273,421.71
Feb 13, 2025 Michele M. Lau EVP and Chief Legal Officer 4,448 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 13, 2025 Michele M. Lau EVP and Chief Legal Officer 3,120 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $595.69 per share 1,858,552.80
Feb 13, 2025 Michele M. Lau EVP and Chief Legal Officer 1,516 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 13, 2025 Michele M. Lau EVP and Chief Legal Officer 3,990 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 13, 2025 LeAnn B. Smith EVP & Chief HR Officer 1,371 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 13, 2025 LeAnn B. Smith EVP & Chief HR Officer 1,239 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $603.4 per share 747,612.60
Feb 13, 2025 LeAnn B. Smith EVP & Chief HR Officer 508 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Mckesson Corp. in the News